• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌氨酸酐与半胱氨酸蛋白酶抑制剂 C 比值与老年人虚弱:一项纵向队列研究。

Creatinine-to-cystatin C ratio and frailty in older adults: a longitudinal cohort study.

机构信息

Department of Geriatrics and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.

出版信息

BMC Geriatr. 2024 Sep 11;24(1):753. doi: 10.1186/s12877-024-05326-1.

DOI:10.1186/s12877-024-05326-1
PMID:39261791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11391795/
Abstract

BACKGROUND

Creatinine-to-cystatin C ratio (CCR) has been associated with multiple adverse outcomes. However, little is known about its relationship with frailty. We aimed to explore the association between CCR and frailty among older adults.

METHODS

A total of 2599 participants aged ≥ 60 years (mean age 67.9 ± 6.0 years, 50.4% males) were included from the China Health and Retirement Longitudinal Study (2011-2015). Baseline CCR was calculated as plasma creatinine (mg/dL) / cystatin C (mg/L) × 10 and was grouped by quartiles. Frailty was evaluated by the validated physical frailty phenotype (PFP) scale and was defined as PFP score ≥ 3. The generalized estimating equations model was used to explore the relationship between CCR and frailty.

RESULTS

The frailty risk decreased gradually with increasing CCR in the quartiles (P for trend = 0.002), and the fourth CCR quartile was associated with a significantly lower risk of frailty compared with the lowest quartile (odds ratio [OR] 0.37, 95% confidence interval [CI] 0.19-0.70). When modeling as a continuous variable, per 1-unit increase in CCR was related to 17% decreased odds of frailty (OR 0.83, 95% CI 0.74-0.93). The association was consistent in male and female participants (P for interaction = 0.41). Poisson models revealed that frailty score was negatively associated with CCR (β= -0.11, 95% CI= -0.19 to -0.04), and sex did not significantly moderate the associations (P for interaction = 0.22). The results were not affected by further adjusting for high-sensitivity C-reactive protein. Similar results were observed by analyses with multiple imputation technique and analyses excluding participants with baseline frailty.

CONCLUSIONS

Higher CCR was associated with a lower frailty risk. CCR may be a simple marker for predicting frailty in older adults.

摘要

背景

肌酸酐-胱抑素 C 比值(CCR)与多种不良结局相关。然而,关于其与虚弱的关系知之甚少。我们旨在探讨老年人中 CCR 与虚弱的关系。

方法

共纳入来自中国健康与退休纵向研究(2011-2015 年)的 2599 名年龄≥60 岁的参与者(平均年龄 67.9±6.0 岁,50.4%为男性)。根据四分位数计算基线 CCR,即血浆肌酸酐(mg/dL)/胱抑素 C(mg/L)×10。采用经过验证的身体虚弱表型(PFP)量表评估虚弱,定义为 PFP 评分≥3。采用广义估计方程模型探讨 CCR 与虚弱的关系。

结果

随着四分位组 CCR 的升高,虚弱风险逐渐降低(趋势 P=0.002),第四分位 CCR 与最低分位相比,虚弱风险显著降低(比值比[OR]0.37,95%置信区间[CI]0.19-0.70)。当作为连续变量建模时,CCR 每增加 1 单位,虚弱的可能性降低 17%(OR 0.83,95%CI0.74-0.93)。该关联在男性和女性参与者中一致(交互作用 P=0.41)。泊松模型显示,虚弱评分与 CCR 呈负相关(β=-0.11,95%CI=-0.19 至-0.04),性别并未显著调节这些关联(交互作用 P=0.22)。进一步调整高敏 C 反应蛋白后,结果仍无变化。采用多重插补技术和排除基线虚弱参与者的分析,也得到了类似的结果。

结论

较高的 CCR 与较低的虚弱风险相关。CCR 可能是预测老年人虚弱的简单标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/191e44de11ec/12877_2024_5326_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/55287506c7fe/12877_2024_5326_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/6f60aa2ec03b/12877_2024_5326_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/112540353f2f/12877_2024_5326_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/b2da99160304/12877_2024_5326_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/191e44de11ec/12877_2024_5326_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/55287506c7fe/12877_2024_5326_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/6f60aa2ec03b/12877_2024_5326_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/112540353f2f/12877_2024_5326_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/b2da99160304/12877_2024_5326_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b520/11391795/191e44de11ec/12877_2024_5326_Fig5_HTML.jpg

相似文献

1
Creatinine-to-cystatin C ratio and frailty in older adults: a longitudinal cohort study.肌氨酸酐与半胱氨酸蛋白酶抑制剂 C 比值与老年人虚弱:一项纵向队列研究。
BMC Geriatr. 2024 Sep 11;24(1):753. doi: 10.1186/s12877-024-05326-1.
2
Lower serum creatinine to cystatin C ratio associated with increased incidence of frailty in community-dwelling elderly men but not in elderly women.血清肌酐与半胱氨酸蛋白酶抑制剂 C 比值降低与社区居住的老年男性虚弱发生率增加相关,但与老年女性无关。
Aging Clin Exp Res. 2024 Jul 4;36(1):140. doi: 10.1007/s40520-024-02787-7.
3
The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).胱抑素 C-与肌酐估算肾小球滤过率的差异及其与虚弱和不良结局的关系:一项收缩压干预试验(SPRINT)的队列分析。
Am J Kidney Dis. 2020 Dec;76(6):765-774. doi: 10.1053/j.ajkd.2020.05.017. Epub 2020 Jul 16.
4
Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline.胱抑素 C 肾功能指标与长期累积性虚弱轨迹和身体功能下降的关系。
JAMA Netw Open. 2022 Sep 1;5(9):e2234208. doi: 10.1001/jamanetworkopen.2022.34208.
5
Association of serum creatinine to cystatin C to waist circumference ratios and hypertension: evidence from China health and retirement longitudinal study.血清肌酐与胱抑素 C 比值及腰围与高血压的相关性:来自中国健康与养老追踪调查的证据。
Front Endocrinol (Lausanne). 2024 May 1;15:1375232. doi: 10.3389/fendo.2024.1375232. eCollection 2024.
6
Cystatin C and frailty in older men.胱抑素 C 与老年男性虚弱
J Am Geriatr Soc. 2013 Sep;61(9):1530-6. doi: 10.1111/jgs.12413. Epub 2013 Sep 3.
7
Cross-Sectional and Longitudinal Associations of Creatinine-to-Cystatin C Ratio with Sarcopenia Parameters in Older Adults.血肌酐-胱抑素 C 比值与老年人肌少症参数的横断面和纵向关联。
J Nutr Health Aging. 2023;27(11):946-952. doi: 10.1007/s12603-023-2029-3.
8
Cystatin C and the Risk of Frailty and Mortality in Older Men.胱抑素C与老年男性衰弱及死亡风险
J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):965-970. doi: 10.1093/gerona/glw223.
9
The creatinine-to-cystatin C ratio (a surrogate marker of muscle mass) as a predictor of lung function decline in older adults: A nationwide longitudinal study in China.肌氨酸酐-胱抑素 C 比值(肌肉量的替代标志物)预测中国老年人群肺功能下降的全国性纵向研究。
Respir Med. 2023 May;211:107197. doi: 10.1016/j.rmed.2023.107197. Epub 2023 Mar 7.
10
Sex differences in the relationship of serum creatinine to cystatin C ratio and depressive symptoms among middle-aged and older adults in China.血清肌酐与半胱氨酸蛋白酶抑制剂 C 比值与中国中老年人群抑郁症状的性别差异。
J Affect Disord. 2022 Dec 15;319:57-61. doi: 10.1016/j.jad.2022.09.030. Epub 2022 Sep 16.

引用本文的文献

1
A cross-sectional and longitudinal cohort study of creatinine-to-cystatin C ratio and cardiovascular disease risk in a middle-aged and elderly population.一项针对中老年人群中肌酐与胱抑素 C 比值及心血管疾病风险的横断面和纵向队列研究。
Front Endocrinol (Lausanne). 2025 May 23;16:1531394. doi: 10.3389/fendo.2025.1531394. eCollection 2025.
2
Association between serum creatinine/cystatin C ratio and symptomatic knee osteoarthritis incidents in Chinese middle-aged and older adults, considering sex variations: findings from the CHARLS.考虑性别差异:中国中老年人群血清肌酐/胱抑素C比值与有症状膝关节骨关节炎发病的关联——基于中国健康与养老追踪调查(CHARLS)的发现
Clin Rheumatol. 2025 Jun 3. doi: 10.1007/s10067-025-07517-6.

本文引用的文献

1
Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.基于血清肌酐和胱抑素 C 的指标对肌肉减少症的诊断准确性:系统评价和荟萃分析。
Age Ageing. 2024 Jan 2;53(1). doi: 10.1093/ageing/afad252.
2
Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China.中国中老年人群血清肌酐与胱抑素C比值和认知功能的关系
Front Aging Neurosci. 2022 Sep 9;14:919430. doi: 10.3389/fnagi.2022.919430. eCollection 2022.
3
Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
血清肌酐/胱抑素C比值是胃肠道间质瘤患者肌肉减少症的一个全身性标志物。
Front Nutr. 2022 Sep 2;9:963265. doi: 10.3389/fnut.2022.963265. eCollection 2022.
4
Sex differences in the relationship of serum creatinine to cystatin C ratio and depressive symptoms among middle-aged and older adults in China.血清肌酐与半胱氨酸蛋白酶抑制剂 C 比值与中国中老年人群抑郁症状的性别差异。
J Affect Disord. 2022 Dec 15;319:57-61. doi: 10.1016/j.jad.2022.09.030. Epub 2022 Sep 16.
5
Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus.肌氨酸酐-胱抑素 C 比值作为肌少症的标志物用于识别 2 型糖尿病男性患者的骨质疏松症。
BMC Musculoskelet Disord. 2022 Jul 14;23(1):672. doi: 10.1186/s12891-022-05636-8.
6
Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes.血清肌酐与胱抑素 C 比值与 2 型糖尿病患者亚临床动脉粥样硬化的关系。
BMJ Open Diabetes Res Care. 2022 Jun;10(3). doi: 10.1136/bmjdrc-2022-002910.
7
Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.基于血清肌酐和胱抑素 C 的诊断指标在晚期非小细胞肺癌中的肌少症诊断。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1800-1810. doi: 10.1002/jcsm.12977. Epub 2022 Mar 17.
8
Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes.血清肌酐与胱抑素 C 的比值低与 2 型糖尿病患者的肌肉减少症和颈动脉斑块评分高独立相关。
Nutr Metab Cardiovasc Dis. 2022 Jun;32(6):1454-1462. doi: 10.1016/j.numecd.2022.02.005. Epub 2022 Feb 11.
9
Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study.标准化肌酐-胱抑素 C 比值与中老年人群糖尿病风险:中国健康与养老追踪调查。
Diabetes Metab J. 2022 May;46(3):476-485. doi: 10.4093/dmj.2021.0074. Epub 2022 Mar 7.
10
Changes in predicted lean body mass, appendicular skeletal muscle mass, and body fat mass and cardiovascular disease.预测的去脂体重、四肢骨骼肌质量和体脂肪量的变化与心血管疾病。
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1113-1123. doi: 10.1002/jcsm.12962. Epub 2022 Feb 25.